Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis—caution with trough concentrations☆
To access this article, please choose from the options below
☆ Presented at the Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, October 14–17, 2004.
PII: S1569-1993(06)00090-7
doi:10.1016/j.jcf.2006.05.015
© 2006 European Cystic Fibrosis Society. Published by Elsevier Inc. All rights reserved.
